XML 50 R39.htm IDEA: XBRL DOCUMENT v3.21.2
Collaboration Agreements, In-Licensing Arrangements And Business Development Activities - Royalty Revenues under the Collaboration Agreement with Genentech (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Oct. 01, 2021
Oct. 02, 2020
Oct. 01, 2021
Oct. 02, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Royalty revenues on ex-U.S. sales $ 328,423 $ 231,092 $ 983,830 $ 717,486
Collaborative Arrangement with Genentech | Cotellic        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Profits on U.S. commercialization 1,743 1,595 5,697 4,378
Royalty revenues on ex-U.S. sales $ 1,576 $ 1,370 $ 3,309 $ 3,804